Stay in touch
Prime news from our network.
Stay in touch
Prime news from our network.
Prof. Dr Ulrich Hacker and his team study tumours at a molecular level to identify genetic changes that can be used for targeted therapies. This data is compared with international databases in order to find suitable treatment options such as immunotherapies or specific drugs. The interdisciplinary team of the Molecular Tumour Board evaluates the results and makes recommendations, also taking clinical studies into account. Despite great progress, not all cases can be treated. But the centre is optimistic that it will be able to help more and more patients. Florian Lordick encourages oncologists to consider personalised medicine, because often more is possible than you think.
Source: Press release Leipzig University Hospital from 01 October 2024
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.